9/12 5:30 pm - 8:30 pm
HBA presents 'Putting Academia-Industry Research Partnerships to Work.' Novartis, 1 Health Plaza, East Hanover, NJ more
9/24 4:00 pm - 6:00 pm
CURE presents healthcare investment banker Anthony Gibney of Leerink Swann. Yale Anlyan Center, 300 Cedar Street, New Haven more
10/1 4:00 pm - 6:00 pm
CURE/Yale BioHaven presents Trevi Therapeutics. Anlyan Center, 300 Cedar Street, New Haven. Watch for details.
10/8-9 12th annual BIO Investor Forum. The Palace Hotel, San Francisco more
10/15 6:00 pm - 9:30 pm
HBA presents Women's Healthcare Innovation and Leadership Showcase. Sanofi Campus, 55 Corporate Drive Auditorium, Bridgewater, NJ more
11/7 10:00 am - 3:00 pm
CT Innovation Summit. Mentor meetings, awards ceremony, and more. Co-sponsored by CURE. Oakdale Theater, Wallingford more
11/11-13 The BIO Convention in China. National Convention Center, Beijing more
12/3 5:45 pm - 7:30 pm
CURE Holiday Party. 'The best networking in town.' Café George, 300 George Street, New Haven. Save the Date!

Cost-saving discounts for CURE members!
CURE members can now receive discounts on various products and services, such as lab supplies, shipping services, and gases more


NovaTract Surgical LLC
5 Science Park, 3rd Floor
401 Winchester Avenue
New Haven, CT 06511

Phone: 203-533-9710
Fax: 203-562-1965
Website: http://www.novatract.com

Contact(s)
Eleanor Tandler - eltandler@novatract.com

General Information
NovaTract is a venture-backed start-up company founded to develop new, innovative laparoscopic medical devices for minimally invasive surgery. Our initial product addresses the need to reduce the number of incisions necessary to perform minimally invasive surgery; therefore, leading to less pain and scarring, and less risk of infection, adhesion or hernias in the abdomen wall, resulting in shorter recovery times.

NovaTract’s devices are developed based on the research and expertise of world-class surgeon, Dr. Kurt E. Roberts, Assistant Professor of General Surgery at Yale University School of Medicine. NovaTract is initially focusing on an internal organ retraction device for use in abdominal surgery; most commonly the removal of the gallbladder (cholecystectomies) and appendix (appendectomies); two markets where laparoscopic surgery with 3-4 incisions is currently the gold standard of care. NovaTract's devices will allow general laparoscopic surgeons worldwide to practice Dr. Roberts’ innovative technique using fewer incisions.

NovaTract was incorporated in April 2010 by its founders: Eleanor L. Tandler, the company’s Chief Executive Officer, and Dr. Roberts. The Company expects its first retraction device to be ready for market in the second half of 2012.

Other Information
CT Employees: 3
World Employees: 3

Back